Lionne N. Grootjen

Oxytocin in young children with Prader‐Willi syndrome: Results of a randomized, double‐blind, placebo‐controlled, crossover trial investigating 3 months of oxytocin

Layla Damen, Lionne N. Grootjen, Alicia F. Juriaans et al. · Clinical Endocrinology · 2020 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Effects of 8 years of growth hormone treatment on scoliosis in children with Prader–Willi syndrome

Lionne N. Grootjen, Joost Rutges, Layla Damen et al. · European Journal of Endocrinology · 2021 · 23 citations · Full text

Medicine, Endocrinology, Pediatrics +13

Long-Term Growth Hormone Treatment of Children with PWS: The Earlier the Start, the Better the Outcomes?

Lionne N. Grootjen, Demi J. Trueba-Timmermans, Layla Damen et al. · Journal of Clinical Medicine · 2022 · 23 citations · Full text

Medicine, Endocrinology, Pediatrics +16

Prenatal and Neonatal Characteristics of Children with Prader-Willi Syndrome

Lionne N. Grootjen, Nathalie E. M. Uyl, Inge A.L.P. van Beijsterveldt et al. · Journal of Clinical Medicine · 2022 · 22 citations · Full text

Life Sciences, Genetics, Pediatrics +17

Three years of growth hormone treatment in young adults with Prader‐Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome

Layla Damen, Lionne N. Grootjen, Stephany Donze et al. · Clinical Endocrinology · 2020 · 18 citations · Full text

Medicine, Endocrinology, Pediatrics +16